ISRCTN ISRCTN70017938
DOI https://doi.org/10.1186/ISRCTN70017938
Secondary identifying numbers HTA 08/14/06
Submission date
18/05/2009
Registration date
20/05/2009
Last edited
25/08/2017
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Mental and Behavioural Disorders
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Background and study aims
Family carers of people with dementia are a group at high risk of mental health problems like depression and anxiety. As they provide most of the care received by people with dementia in this country, and the number of people with dementia is projected to increase substantially, there is an urgent need within society to develop ways to decrease their distress. The UK government has recognised that family dementia carers need dedicated psychological therapies, and that this should be a key component of high quality dementia care, but in practice resources are not available. The only studies that have demonstrated efficacy of a manual based psychological therapy in this group were carried out in the
USA and the therapy was conducted by clinical psychologists. Clinical psychologists are a highly trained and finite resource within the NHS. Researchers in the USA have developed a talking therapy programme to help family or friends of people with memory problems. This has been adapted this for Britain (for example; seeing people individually rather than in groups). The aim of this study is to test whether this programme is effective in friends and relatives of people with memory problems in the UK.

Who can participate?
Family carers who provide emotional or practical support at least weekly and identify themselves as the primary carer of someone with dementia not living in 24 hour care and who are carers of patients referred in the last year.

What does the study involve?
An interviewer conducts an initial interview. This takes about an hour. They ask participants about their relative/friend's memory and behavioural symptoms, difficulties they may have with their daily routine, their and their relative's/friend's health, services that provide assistance to their friend/relative, and the rewards and difficulties of caring including how they have coped with these difficulties over recent times. A researcher (the same person if possible) visits again 4, 8, 12 and 24 months after the initial interview. At these visits, they ask some of the same questions again to see whether things have changed. Participants are randomly allocated to one of two groups after the first interview. The first group do not receive any extra visits apart from the researcher coming back to see how they are getting on. In the second group a psychological therapist conducts eight talking therapy sessions. The first visit is shortly after the first interview, and the meetings are weekly for eight sessions. The meetings are scheduled for a time and place that is convenient, and most people prefer this to be at their home. Each lasts about an hour. The psychological therapist is someone who has received training to deliver this programme. Participants are encouraged to discuss recent problems that have arisen while helping the person with memory problems and what to do. Participants are also given brief exercises to do between sessions, for example, making a note of incidents which cause stress. With consent some of the sessions are tape recorded for later analysis, to ensure that the therapy is being delivered correctly. The study does not involve the person with memory problems, and no specific additional care is offered. Participants are followed up every six months from 2 years until the person with dementia goes into a care home or dies, or for 6 years.

What are the possible benefits and risks of participating?
It cannot be promised that the study will help the participants. It will provide evidence regarding whether the programme is helpful for family and friends of people with memory problems. If it is, then knowing this could help improve the support offered to family and friends of people with memory problems. It is not anticipated that there will be any disadvantages to taking part except for the inconvenience of making time for the interviews and the talking therapy sessions, but it is possible that some topics discussed concerning the stresses of caring may be upsetting.

Where is the study run from?
University College London (UK)

When is the study starting and how long is it expected to run for?
August 2009 to December 2018

Who is funding the study?
Health Technology Assessment Programme (UK)

Who is the main contact?
Prof. Gill Livingston
g.livingston@ucl.ac.uk

Contact information

Prof Gill Livingston
Scientific

University College London
Holborn Union Building
Archway Campus
Highgate Hill
London
N19 5NL
United Kingdom

Phone +44 (0)20 7561 4218
Email g.liivngston@ucl.ac.uk

Study information

Study designRandomised multi-centre single-blind controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Other
Study typeQuality of life
Participant information sheet Not available in web format, please use the contact details to request a patient information sheet
Scientific titleSTART (STrAtegies for RelaTives) study: a pragmatic randomised controlled trial to determine the effectiveness of a manual based coping strategy programme in promoting the mental health of carers of people with dementia
Study acronymSTART
Study objectivesThat eight sessions of manual based coping strategy therapy, delivered over 8-14 weeks by supervised graduate mental health workers is clinically (in terms of anxiety and depressive symptoms) and cost-effectiveness for family carers, compared to usual care.
Ethics approval(s)East London and the City Research Ethics Committee 1, 11/08/2009, ref: 09/H0703/84
Approval for substantial amendment on 11/09/2011
Health condition(s) or problem(s) studiedFamily carer of patient with dementia
InterventionAn interviewer conducts an initial interview. This takes about an hour. They ask participants about their relative/friend's memory and behavioural symptoms, difficulties they may have with their daily routine, their and their relative's/friend's health, services that provide assistance to their friend/relative, and the rewards and difficulties of caring including how they have coped with these difficulties over recent times. A researcher (the same person if possible) visits again 4, 8, 12 and 24 months after the initial interview. At these visits, they ask some of the same questions again to see whether things have changed. Participants are randomly allocated to one of two groups after the first interview. The first group do not receive any extra visits apart from the researcher coming back to see how they are getting on. In the second group a psychological therapist conducts eight talking therapy sessions. The first visit is shortly after the first interview, and the meetings are weekly for eight sessions. The meetings are scheduled for a time and place that is convenient, and most people prefer this to be at their home. Each lasts about an hour. The psychological therapist is someone who has received training to deliver this programme. Participants are encouraged to discuss recent problems that have arisen while helping the person with memory problems and what to do. Participants are also given brief exercises to do between sessions, for example, making a note of incidents which cause stress. With consent some of the sessions are tape recorded for later analysis, to ensure that the therapy is being delivered correctly. The study does not involve the person with memory problems, and no specific additional care is offered.

Added 24/08/2017:
Participants are followed up every six months from 2 years until the person with dementia goes into a care home or dies, or for 6 years.
Intervention typeOther
Primary outcome measureCurrent primary outcome measures as of 10/05/2013:
1. Carer HADS Total
2. Cost-effectiveness: Cost of care for each group will be measured using the Client Service Receipt Inventory (CSRI). The EQ5D is a generic measure to generate QALYs (quality of life adjusted health years); societal weights will be applied.

At 2 years:
1. Carer HADS Total
2. Cost-effectiveness: Cost of care for each group will be measured using the Client Service Receipt Inventory (CSRI). The EQ5D is a generic measure to generate QALYs (quality of life adjusted health years); societal weights will be applied.

At 7 years:
Time to entry to 24 care

Previous primary outcome measures until 10/05/2013:
1. Carer HADS depression and anxiety scores
2. Cost-effectiveness: Cost of care for each group will be measured using the Client Service Receipt Inventory (CSRI). The EQ5D is a generic measure to generate QALYs (quality of life adjusted health years); societal weights will be applied.
Secondary outcome measuresCurrent secondary outcome measures as of 10/05/2013:
At 8 months:
1 Depression and anxiety caseness and scores on the HADS
2. Carer (HSQ mental health) and care recipient (QoL-AD) quality of life
3. Modified Conflict Tactics Scale

At 2 years:
1 Time to entry of the person with dementia to 24-hr care
2 Depression and anxiety caseness and scores on the HADS
3 Carer (HSQ mental health) and care recipient (QoL-AD) quality of life
4. Modified Conflict Tactics Scale

Previous secondary outcome measures until 10/05/2013:
1. Time to entry of the person with dementia to 24-hr care
2. Depression and anxiety caseness on the HADS
3. Carer (HSQ) and care recipient (QoL-AD) quality of life
4. Modified Conflict Tactics Scale
Overall study start date01/08/2009
Completion date31/12/2018

Eligibility

Participant type(s)Carer
Age groupAdult
Lower age limit18 Years
SexBoth
Target number of participants258
Key inclusion criteria1. Family carers who provide emotional or practical support at least weekly and identify themselves as the primary carer of someone with dementia not living in 24 hour care referred in the last year
2. Participants must be over 18 years of age and can be of either sex
Key exclusion criteria1. Carers who are unable to give informed consent to the trial, for example because they have dementia themselves
2. Carers who are currently taking part in a randomised clinical trial in their capacity as a family carer
3. Carers who live more than 1.5 hours from the researchers' base
Date of first enrolment01/08/2009
Date of final enrolment01/06/2011

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

University College London
London
N19 5NL
United Kingdom

Sponsor information

University College London (UK)
University/education

c/o Dr O. Avwenagha
Research Governance Co-ordinator
Joint UCLH/UCL Biomedical Research Unit
R&D Directorate (Maple House)
Rosenheim Wing (Ground Floor)
25 Grafton Way
London
WC1E 5DB
England
United Kingdom

Phone +44 (0)20 7380 9928
Email o.avwenagha@ucl.ac.uk
Website http://www.ucl.ac.uk
ROR logo "ROR" https://ror.org/02jx3x895

Funders

Funder type

Government

Health Technology Assessment Programme
Government organisation / National government
Alternative name(s)
NIHR Health Technology Assessment Programme, HTA
Location
United Kingdom

Results and Publications

Intention to publish date31/12/2019
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryData sharing statement to be made available at a later date
Publication and dissemination planPlanned publication in a high-impact peer reviewed journal.
IPD sharing planThe data sharing plans for the current study are unknown and will be made available at a later date.

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article clinical effectiveness results 25/10/2013 Yes No
Results article cost effectiveness results 25/10/2013 Yes No
Other publications participants' views 04/06/2014 Yes No
Other publications HTA report 01/10/2014 Yes No
Results article coping strategies results 01/10/2014 Yes No
Results article main results 01/12/2014 Yes No
Results article reducing abuse results 01/06/2016 Yes No
Results article dissemination results 21/08/2017 Yes No
HRA research summary 28/06/2023 No No

Editorial Notes

25/08/2017: Publication and dissemination plan, IPD sharing statement and publication references added.
10/05/2013: The overall trial end date was updated from 31/12/2013 to 31/12/2018.